Médecins Sans Frontières
By
Médecins Sans Frontières
Published: March 31, 2015, 9:47 p.m.·
Tags:
Advocacy,
Global TB response,
Research and development
Médecins Sans Frontières calls on the European Union to take concrete actions to boost the regional fight against TB, including tripling European funding for research and development.
Read More →
By
Médecins Sans Frontières
Published: March 27, 2015, 5:09 p.m.·
Tags:
Drug-resistant TB,
TB care
The decentralised model is aimed at diagnosing and treating the majority of DR-TB patients in primary health clinics, instead of being required to be hospitalised for up to six months.
Read More →
By
Médecins Sans Frontières
Published: March 24, 2015, 8:59 p.m.·
Tags:
Global TB response,
Drug-resistant TB,
Advocacy
Lack of political commitment will jeopardize momentum for stronger TB action across the region.
Read More →
By
Médecins Sans Frontières
Published: March 20, 2015, 10:35 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Medicines,
Access,
Advocacy
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Read More →
By
Médecins Sans Frontières
Published: March 20, 2015, 3:01 p.m.·
Tags:
Diagnostics,
Drug-resistant TB
It is essential to conduct studies that can determine whether this mutation is present in neighboring countries such as South Africa or Mozambique: “If we’re facing wide distribution of this strain in Southern Africa or elsewhere, it is imperative that the rapid molecular tests we currently use, as well as those under development, be adapted to detect a wider range of mutations”.
Read More →
By
Médecins Sans Frontières
Published: March 4, 2015, 11:55 p.m.·
Tags:
Global TB response,
Advocacy
Ahead of the 1st Eastern Partnership Ministerial Conference on Tuberculosis (TB) and Multidrug Resistant Tuberculosis due to be held in Riga, Latvia on March 30-31, 2015 Médecins Sans Frontières (MSF) shares their experience and recommedations on how to address the deadly gaps in fighting TB.
Read More →
By
Médecins Sans Frontières
Published: Feb. 17, 2015, 7:25 p.m.·
Tags:
TB care,
Treatment,
Access,
Drug-resistant TB
A medical forum in Armenia gathers health authorities and specialists to discuss tuberculosis, one of the main public health issues in the region. New drugs and therapeutic approaches give hope of better treatment outcomes. Joint and renewed efforts are needed to obtain a better access to the most effective drugs and new treatment regimens for the resistant form of the disease.
Read More →
By
Médecins Sans Frontières
Published: Jan. 22, 2015, 10:12 p.m.·
Tags:
Access,
Advocacy
New Delhi, 21 January, 2014—Ahead of US President Obama’s visit to India, the international medical humanitarian organisation Médecins Sans Frontières/ Doctors Without Borders (MSF) expressed deep concern over the US government’s heightened efforts to undermine access to affordable medicines from India—often called the ‘pharmacy of the developing world.’ Millions of people across the globe rely on Indian low-cost generics, just as MSF relies on these to carry out its medical work.
Read More →
By
Médecins Sans Frontières
Published: Dec. 19, 2014, 10 p.m.·
Tags:
Global TB response
A recent resurgence of TB and the spread of drug-resistant forms makes it an urgent concern.
Read More →
Page 2 of 8 · Total posts: 10
←First
1
2
3
Last→